Table VI.
The activity of the combination of cloxacillin, thioridazine, and miconazole against MSSA strains in vitro.
| Strain | CXN | TZ | MCZ | CXN | TZ | MCZ | FICI |
|---|---|---|---|---|---|---|---|
| MICs (Single) | MICs (Synergy) | ||||||
| MSSA10 | 16 | 64 | 4 | 4 | 4 | 0.25 | 0.38 |
| MSSA13 | 8 | 64 | 8 | 8 | 4 | 0.25 | 1.09 |
| MSSA14 | 8 | 32 | 2 | 8 | 4 | 0.25 | 1.25 |
| MSSA31 | 16 | 32 | 2 | 4 | 4 | 0.25 | 0.50 |
| MSSA36 | 16 | 32 | 1 | 0.015625 | 4 | 0.25 | 0.38 |
| MSSA41 | 8 | 32 | 1 | 4 | 4 | 0.25 | 0.88 |
| MSSA42 | 16 | 64 | 8 | 0.125 | 4 | 0.25 | 0.10 |
| MSSA44 | 16 | 32 | 1 | 0.5 | 4 | 0.25 | 0.41 |
| MSSA50 | 16 | 32 | 1 | 0.125 | 4 | 0.25 | 0.38 |
| MSSA51 | 16 | 32 | 2 | 0.001975 | 4 | 0.25 | 0.25 |
| MSSA54 | 16 | 16 | 2 | 0.0625 | 4 | 0.25 | 0.38 |
| MSSA56 | 16 | 32 | 2 | 0.03125 | 4 | 0.25 | 0.25 |
| MSSA62 | 16 | 32 | 2 | 0.0009715 | 4 | 0.25 | 0.25 |
| MSSA65 | 16 | 32 | 2 | 0.125 | 4 | 0.25 | 0.26 |
| MSSA66 | 16 | 32 | 4 | 4 | 4 | 0.25 | 0.44 |
| MSSA67 | 16 | 32 | 4 | 8 | 4 | 0.25 | 0.69 |
| MSSA68 | 16 | 32 | 4 | 16 | 4 | 0.25 | 1.19 |
| MSSA70 | 16 | 32 | 4 | 0.015625 | 4 | 0.25 | 0.19 |
| MSSA72 | 16 | 64 | 8 | 0.5 | 4 | 0.25 | 0.13 |
| MSSA73 | 16 | 32 | 2 | 0.0625 | 4 | 0.25 | 0.25 |
| MSSA78 | 8 | 16 | 2 | 0.03125 | 4 | 0.25 | 0.38 |
| MSSA79 | 8 | 16 | 4 | 0.03125 | 4 | 0.25 | 0.32 |
| MSSA80 | 16 | 32 | 4 | 0.0078125 | 4 | 0.25 | 0.19 |
| ATCC 29213 | 4 | 16 | 4 | 0.0156 | 4 | 0.50 | 0.38 |
See FICI criteria for details.
MCZ – miconazole; TZ – thioridazine; CXN – cloxacillin;
FIC of drug A (FICA) = MIC of drug A in combination / MIC of drug A alone;
FIC of drug B (FICB) = MIC of drug B in combination / MIC of drug B alone;
Combination FIC(AB) = Σ FIC = FICA + FICB;
Synergistic (Σ FIC ≤ 0.5);
Partially synergistic (Σ FIC > 0.5 and ≤ 1.0);
Indifferent (Σ FIC > 1 and ≤ 4);
Antagonistic (Σ FIC > 4).